Working… Menu

Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Patients (DARWIN2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01894516
Recruitment Status : Completed
First Posted : July 10, 2013
Last Update Posted : May 17, 2016
Information provided by (Responsible Party):
Galapagos NV

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2015
Actual Study Completion Date : July 2015
Certification/Extension First Submitted : April 18, 2016